Medtronic Minimed, Inc.

Minimed, Inc.

Other

Visionary Medical Products Corp. Inc.

Thomas P. Castellano

Paul H. Kovelman

Paul H Kovelman

Sheldon B Moberg

Ian B Hanson

Paul F Bente, Iv

Julian D Kavazov

R Paul Mounce

Christopher G Griffin

Susie E Maule

Melissa D Norton

Bradley J Enegren

Mark Dominis Holt

Robert M Guezuraga

Afshin Bazargan

Salman Monirabbasi

Pablo Vazquez

Truong Gia Luan

Arin N Holecek

Paul F Bente

Anirban Roy

John Joseph Mastrototaro

William P Van Antwerp

James D Causey, Iii

Cary D Talbot

Colin A Chong

Desmond Barry Keenan

Poonam S Gulati

Susan McConnell

Richard E Purvis

Gary Williams

Thomas P Castellano

Biju Nair

Darren Y K Yap

Linda I Torres

John C Mueller, Jr

Gary Cohen

Philip J Hudak

Mike Charles Vallet Tolle

Eric P Geismar

Ruth Marie Tieck

Carol L Davis

Tamir Nitzan

Kenneth Ko

Vidya Raman

Kristen Getschmann

Bee Hess

Cary Talbot

Iv Paul F Bente

Paul R Mounce

Paul F Iv Bente

Gary L Williams

James D Iii Causey

Mike Charles Tolle

John C Mueller

Presented here are techniques for controlling glucose levels of a patient based on predicted time to a target glucose level. One methodology predicts a trajectory of the blood glucose level based on past observations of the blood glucose level, determines a cost expression based on the trajectory, and affects a future command to an infusion pump to affect a cost value according to the cost expression. Another methodology defines a target blood glucose concentration level for the patient, observes a current blood glucose concentration for the patient based on signals received from a blood-glucose sensor, and predicts a duration of time for the patient's blood glucose concentration to reach the target blood glucose concentration level based on the observed current blood glucose concentration.

Predicted time to assess and/or control a glycemic state

Closed-loop control of glucose according to a predicted blood glucose trajectory

A method of diabetes analysis includes receiving a plurality of glucose level readings for a user. A common event occurrence in at least two of the glucose level readings is determined. The at least two glucose level readings from the common event occurrence onwards in time for a time period is analyzed. A glucose level pattern formed by the at least two glucose level readings having a similar shape is determined. At least one anomalous glucose level reading having the similar shape and not conforming to the glucose level pattern is analyzed. The at least one anomalous glucose level reading is adapted to the pattern to form an adapted glucose level pattern. An insulin dosage for the time period beginning at the common event occurrence is calculated based on the adapted glucose level pattern.

Pattern recognition and filtering in a therapy management system

A delivery device includes first and second housing portions that selectively engage and disengage. A reservoir on one housing portion operatively engages a drive device and/or a needle inserting device on the other housing portion. Upon proper engagement of the housing portions, the reservoir operatively couples to the drive device and/or the needle inserting device. A first magnet on the first housing portion and a second magnet (or a magnetically-attractive material) on the second housing portion are positioned to magnetically interact with each other, upon operative engagement of the housing portions. A third magnet on the second housing portion may be opposed to the first magnet to help align the housing portions for connection. A magnet-responsive device may be on one or both housing portions to detect alignment and/or connection of the housing portions.

Infusion medium delivery device and method with drive device for driving plunger in reservoir

A system includes a durable portion with a durable housing and a separable disposable portion with a disposable housing that selectively engage with and disengage from each other. The disposable housing secures to a patient and may be disposed of after it has been in use for a prescribed period. Components that normally come into contact with a patient or with an infusion medium may be part of the disposable portion to allow for disposal after a prescribed use. A reservoir for holding the infusion medium may be part of the disposable portion, and may be supported by the disposable housing. The durable portion may include other components such as electronics for controlling delivery of the infusion medium from the reservoir, and a drive device including a motor and drive linkage.

Systems and methods allowing for reservoir filling and infusion medium delivery

A system for identifying a reservoir used with a fluid delivery device. The system includes a reservoir comprising a housing for holding fluid and a colored marking located on a surface of the housing. A fluid delivery device includes a compartment for receiving and operatively coupling with the reservoir. A light source shines light on the colored marking of the reservoir. A color sensor detects wavelengths reflected and/or refracted from the colored marking due to the light shined on the colored marking. A processor of the delivery device determines a color of the colored marking from the detected wavelengths and ascertains information related to the reservoir or the fluid in the reservoir corresponding to the determined color, wherein the processor operates the fluid delivery device according to the ascertained information, wherein the information may include a reservoir type and/or medication type.

Color detection system for detecting reservoir presence and content in device

A delivery device includes a durable housing portion and a separable disposable portion that selectively engage and disengage from each other. The disposable housing portion secures to the patient-user and may be disposed of after it has been in use for a prescribed period. Components that normally come into contact with a patient-user or with infusion medium are supported by the disposable housing portion, while the durable housing portion supports other components such as electronics and a drive device. A reservoir is supported by the disposable housing portion and has a moveable plunger that operatively couples to the drive device, when the disposable and durable housing portions are engaged.

An infusion set is provided for use in delivering fluid through a cannula, which is housed on a cannula housing, to a selected subcutaneous infusion site on a patient. The fluid is generally a medication, for example, insulin. The cannula is in fluid communication with a fluid passageway surrounded by a projection on the cannula housing that includes one or more rail-like extensions acting as connection guides. A connector connects the cannula housing to a fluid delivery system, such as an infusion pump. The connector includes a connecting needle and one or more guide arms that slide over the rail-like extensions to guide the needle into the self-sealing septum. The connector includes one or more locking arms, with barbs at the end, to connect with one or more recesses that are provided in the cannula housing.

Medication infusion set

Growing community of inventors

Simi Valley, CA, United States of America

Paul H Kovelman